Publications found:
73,128
Sort by:
Tularaemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Tularaemia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Tularaemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
40 pages
Cryptosporidiosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cryptosporidiosis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Cryptosporidiosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
30 pages
Osteonecrosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Osteonecrosis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Osteonecrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
31 pages
Gliosarcoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Gliosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gliosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
350 pages
Hypoparathyroidism - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hypoparathyroidism (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypoparathyroidism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
70 pages
Pemphigus Vulgaris - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Pemphigus Vulgaris (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Pemphigus Vulgaris and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
92 pages
Systemic Mastocytosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Systemic Mastocytosis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Systemic Mastocytosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
178 pages
Anaphylaxis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Anaphylaxis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Anaphylaxis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
58 pages
Gallbladder Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Gallbladder Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Gallbladder Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
695 pages
Hypothyroidism - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hypothyroidism (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypothyroidism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
32 pages
Impetigo - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Impetigo (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Impetigo and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
45 pages
Peritonitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Peritonitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Peritonitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
45 pages
Pigmented Villonodular Synovitis - Pipeline Review, H1 2020
US$ 2,000.00
... . The Pigmented Villonodular Synovitis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Pigmented Villonodular Synovitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
76 pages
Vaginal Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Vaginal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Vaginal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
381 pages
Anaplastic Oligoastrocytoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Anaplastic Oligoastrocytoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Anaplastic Oligoastrocytoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
83 pages
Axial Spondyloarthritis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Axial Spondyloarthritis (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Axial Spondyloarthritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
251 pages
Burkholderia pseudomallei Infections (Melioidosis) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Burkholderia pseudomallei Infections (Melioidosis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Burkholderia pseudomallei Infections (Melioidosis) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
May 2020
46 pages
Dermatomyositis - Pipeline Review, H1 2020
US$ 2,000.00
... ) pipeline guide also reviews of key players involved in therapeutic development for Ankylosing Spondylitis (Bekhterev's Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
123 pages
Fanconi Anemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Fanconi Anemia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fanconi Anemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
83 pages
Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Heterozygous familial hypercholesterolemia (heFH) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Heterozygous familial hypercholesterolemia (heFH) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
May 2020
109 pages
Hypereosinophilic Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hypereosinophilic Syndrome (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hypereosinophilic Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
108 pages
Nephrotic Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Nephrotic Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
50 pages
Pontine Glioma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Pontine Glioma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Pontine Glioma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2020
469 pages
Progressive Multifocal Leukoencephalopathy - Pipeline Review, H1 2020
US$ 2,000.00
... . The Progressive Multifocal Leukoencephalopathy (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Progressive Multifocal Leukoencephalopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
30 pages
Secondary (Hypogonadotropic) Hypogonadism - Pipeline Review, H1 2020
US$ 2,000.00
... . The Secondary (Hypogonadotropic) Hypogonadism (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Secondary (Hypogonadotropic) Hypogonadism and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
66 pages
Spinocerebellar Ataxia (SCA) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Spinocerebellar Ataxia (SCA) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Spinocerebellar Ataxia (SCA) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
104 pages
20s Proteasome - Pipeline Review, H1 2020
US$ 3,500.00
... reviews 20s Proteasome targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
May 2020
76 pages
Lung Transplant Rejection - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Lung Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Lung Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
89 pages
Rubella (German Measles) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Rubella (German Measles) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rubella (German Measles) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
May 2020
40 pages
Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H1 2020
US$ 3,500.00
... Hepatitis C Virus Envelope Protein E2 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
May 2020
34 pages
Metabotropic Glutamate Receptor 2 - Pipeline Review, H1 2020
US$ 3,500.00
... Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
May 2020
53 pages
Metabotropic Glutamate Receptor 5 - Pipeline Review, H1 2020
US$ 3,500.00
... Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
May 2020
76 pages
Insulin Like Growth Factor I - Pipeline Review, H1 2020
US$ 3,500.00
... Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
May 2020
52 pages
Insulin Like Growth Factor II - Pipeline Review, H1 2020
US$ 3,500.00
... reviews Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
May 2020
48 pages
Metabotropic Glutamate Receptor 3 - Pipeline Review, H1 2020
US$ 3,500.00
... Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
May 2020
36 pages
Prostaglandin E2 Receptor EP4 Subtype - Pipeline Review, H1 2020
US$ 3,500.00
... Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
May 2020
66 pages
C-C Chemokine Receptor Type 5 - Pipeline Review, H1 2020
US$ 3,500.00
C-C Chemokine Receptor Type 5 - Pipeline Review, H1 2020 SUMMARY C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) pipeline Target constitutes close to 15 molecules...
May 2020
108 pages
Catenin Beta 1 - Pipeline Review, H1 2020
US$ 3,500.00
Catenin Beta 1 - Pipeline Review, H1 2020 SUMMARY Catenin Beta 1 (Beta Catenin or CTNNB1) pipeline Target constitutes close to 14 molecules. Out of which approximately 12 molecules are developed by...
May 2020
69 pages
Complement C5 - Pipeline Review, H1 2020
US$ 3,500.00
Complement C5 - Pipeline Review, H1 2020 SUMMARY Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) pipeline Target constitutes close to 34 molecules. Out of whi...
May 2020
167 pages
Cyclin Dependent Kinase 2 - Pipeline Review, H1 2020
US$ 3,500.00
Cyclin Dependent Kinase 2 - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Cyclin Dependent Kinase 2 – Pipeline Review, H1 2020'; Cyclin Dependent Kinase 2 (p33 Protein...
May 2020
86 pages
Cyclin Dependent Kinase 6 - Pipeline Review, H1 2020
US$ 3,500.00
Cyclin Dependent Kinase 6 - Pipeline Review, H1 2020 SUMMARY Cyclin Dependent Kinase 6 (Cell Division Protein Kinase 6 or Serine/Threonine Protein Kinase PLSTIRE or CDK6 or EC 2.7.11.22) pipeline Ta...
May 2020
176 pages
Fibroblast Growth Factor 2 - Pipeline Review, H1 2020
US$ 3,500.00
Fibroblast Growth Factor 2 - Pipeline Review, H1 2020 SUMMARY Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) – Basic fibroblast growth factor...
May 2020
53 pages
Gingivitis - Pipeline Review, H1 2020
US$ 2,000.00
Gingivitis - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gingivitis – Pipeline Review, H1 2020, provides an overview of the G...
May 2020
32 pages
Glucokinase - Pipeline Review, H1 2020
US$ 3,500.00
Glucokinase - Pipeline Review, H1 2020 SUMMARY Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close to 14 molecules. Out of which approximately 12 molecu...
May 2020
67 pages
Glycogen Synthase Kinase 3 Beta - Pipeline Review, H1 2020
US$ 3,500.00
Glycogen Synthase Kinase 3 Beta - Pipeline Review, H1 2020 SUMMARY Glycogen Synthase Kinase 3 Beta (Serine/Threonine Protein Kinase GSK3B or GSK3B or EC 2.7.11.26 or EC 2.7.11.1) – Glycogen synthase...
May 2020
69 pages
Glycoprotein 41 - Pipeline Review, H1 2020
US$ 3,500.00
Glycoprotein 41 - Pipeline Review, H1 2020 SUMMARY Glycoprotein 41 (gp41) – Gp41 or glycoprotein 41 is a transmembrane protein that contains several sites within its ectodomain that are required for...
May 2020
66 pages
Protein Kinase C Epsilon Type - Pipeline Review, H1 2020
US$ 3,500.00
Protein Kinase C Epsilon Type - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Protein Kinase C Epsilon Type – Pipeline Review, H1 2020'; Protein Kinase C Epsilon Type...
May 2020
58 pages
